Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms

References

• 1 US FDA. Paving the way for personalized medicine (2013). https://www.fdanews.com/ext/resources/files/10/10-28-13-Personalized-Medicine.pdf (last accessed on January 11th 2018).
  Google Scholar
• 2 Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: opportunities and challenges. Pharm. Res. 33(8), 1817–1832 (2016).
  Medline CASGoogle Scholar
• 3 Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur. J. Pharm. Sci. 68, 11–17 (2015).
  Medline CASGoogle Scholar
• 4 Tagami T, Nagata N, Hayashi N et al. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler. Int. J. Pharm. 543(1–2), 361–367 (2018).
  Medline CASGoogle Scholar
• 5 Davoodi P, Lee LY, Xu Q et al. Drug delivery systems for programmed and on-demand release. Adv. Drug Deliv. Rev. 132, 104–138 (2018).
  Medline CASGoogle Scholar
• 6 Goyanes A, Wang J, Buanz A et al. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol. Pharm. 12(11), 4077–4084 (2015).
  Medline CASGoogle Scholar
• 7 Lim SH, Kathuria H, Tan JJY, Kang L. 3D printed drug delivery and testing systems – a passing fad or the future? Adv. Drug Deliv. Rev. 132, 139–168 (2018).
  Medline CASGoogle Scholar
• 8 Lopez FL, Ernest TB, Tuleu C, Gul MO. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin. Drug Deliv. 12(11), 1727–1740 (2015).
  Medline CASGoogle Scholar
• 9 Pardeike J, Strohmeier DM, Schrodl N et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int. J. Pharm. 420(1), 93–100 (2011).
  Medline CASGoogle Scholar
• 10 Raijada D, Genina N, Fors D et al. A step toward development of printable dosage forms for poorly soluble drugs. J. Pharm. Sci. 102(10), 3694–3704 (2013).
  Medline CASGoogle Scholar
• 11 Sadee W. Personalized therapeutics and pharmacogenomics: integral to personalized health care. Pharm. Res. 34(8), 1535–1538 (2017).
  Medline CASGoogle Scholar
• 12 Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int. J. Pharm. 404(1–2), 1–9 (2011).
  Medline CASGoogle Scholar
• 13 Ricles LM, Coburn JC, Di Prima M, Oh SS. Regulating 3D-printed medical products. Sci. Transl. Med. 10(461), eaan6521 (2018).
  MedlineGoogle Scholar
• 14 Awad A, Trenfield SJ, Gaisford S, Basit AW. 3D printed medicines: a new branch of digital healthcare. Int. J. Pharm. 548, 586–596 (2018).
  Medline CASGoogle Scholar
• 15 Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 3D printing in pharmaceutical and medical applications – recent achievements and challenges. Pharm. Res. 35(9), 176 (2018).
  MedlineGoogle Scholar
• 16 Awad A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. Reshaping drug development using 3D printing. Drug Discov. Today 23, 1547–1555 (2018).
  Medline CASGoogle Scholar
• 17 Goyanes A, Robles Martinez P, Buanz A, Basit AW, Gaisford S. Effect of geometry on drug release from 3D printed tablets. Int. J. Pharm. 494(2), 657–663 (2015).
  Medline CASGoogle Scholar
• 18 Jamroz W, Kurek M, Lyszczarz E et al. 3D printed orodispersible films with aripiprazole. Int. J. Pharm. 533(2), 413–420 (2017).
  Medline CASGoogle Scholar
• 19 Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol. Sci. 39(5), 440–451 (2018).
  Medline CASGoogle Scholar
• 20 Alhijjaj M, Belton P, Qi S. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur. J. Pharm. Biopharm. 108, 111–125 (2016).
  Medline CASGoogle Scholar
• 21 Goole J, Amighi K. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int. J. Pharm. 499(1–2), 376–394 (2016).
  MedlineGoogle Scholar
• 22 Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv. Drug Deliv. Rev. 108, 39–50 (2017).
  Medline CASGoogle Scholar
• 23 Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan KW, Alhnan MA. A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm. Res. 33(11), 2704–2712 (2016).
  Medline CASGoogle Scholar
• 24 Sadia M, Sosnicka A, Arafat B et al. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int. J. Pharm. 513(1–2), 659–668 (2016).
  Medline CASGoogle Scholar
• 25 Ghosh U, Ning S, Wang Y, Kong YL. Addressing unmet clinical needs with 3D printing technologies. Adv. Healthcare Mater. 7(17), 1800417 (2018).
  Google Scholar
• 26 Fuenmayor E, Forde M, Healy AV et al. Material considerations for fused-filament fabrication of solid dosage forms. Pharmaceutics 10(2), 44 (2018).
  Google Scholar
• 27 Sadia M, Arafat B, Ahmed W, Forbes RT, Alhnan MA. Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets. J. Control. Rel. 269, 355–363 (2018).
  Medline CASGoogle Scholar
• 28 Solanki NG, Tahsin M, Shah AV, Serajuddin ATM. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-polymer miscibility and printability. J. Pharm. Sci. 107(1), 390–401 (2018).
  Medline CASGoogle Scholar
• 29 Jonathan G, Karim A. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int. J. Pharm. 499(1–2), 376–394 (2016).
  Medline CASGoogle Scholar
• 30 Zhang J, Feng X, Patil H, Tiwari RV, Repka MA. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int. J. Pharm. 519(1–2), 186–197 (2017).
  Medline CASGoogle Scholar
• 31 Sun Y, Rui Y, Wenliang Z, Tang X. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int. J. Pharm. 359(1–2), 144–149 (2008).
  Medline CASGoogle Scholar
• 32 Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur. J. Pharm. Biopharm. 89, 157–162 (2015).
  Medline CASGoogle Scholar
• 33 Khaled SA, Burley JC, Alexander MR, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int. J. Pharm. 461(1–2), 105–111 (2014).
  Medline CASGoogle Scholar
• 34 Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur. J. Pharm. Biopharm. 96, 380–387 (2015).
  Medline CASGoogle Scholar
• 35 Solanki NG, Tahsin M, Shah AV, Serajuddin ATM. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-polymer miscibility and printability. J. Pharma. Sci. 107(1), 390–401 (2018).
  Medline CASGoogle Scholar
• 36 Konta A, García-Piña M, Serrano D. Personalised 3D printed medicines: which techniques and polymers are more successful? Bioengineering 4(4), 79 (2017).
  Google Scholar
• 37 Goyanes A, Fernández-Ferreiro A, Majeed A et al. PET/CT imaging of 3D printed devices in the gastrointestinal tract of rodents. Int. J. Pharm. 536(1), 158–164 (2018).
  Medline CASGoogle Scholar
• 38 Choonara YE, Du Toit LC, Kumar P, Kondiah PP, Pillay V. 3D-printing and the effect on medical costs: a new era? Expert Rev. Pharmacoeconomics Outcomes Res. 16(1), 23–32 (2016).
  MedlineGoogle Scholar
• 39 Sanphui P, Rajput L. Tuning solubility and stability of hydrochlorothiazide co-crystals. Acta Crystallogr. B 70(1), 81–90 (2014).
  CASGoogle Scholar
• 40 Palekar S, Nukala PK, Mishra SM, Kipping T, Patel K. Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen. Int. J. Pharm. 556, 106–116 (2018).
  MedlineGoogle Scholar
• 41 Patki M, Patel K. Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient. Drug Dev. Ind. Pharm. 1–10 (2018).
  MedlineGoogle Scholar
• 42 Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 21(10), 1762–1769 (2004).
  Medline CASGoogle Scholar
• 43 Liu F, Ranmal S, Batchelor HK et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs 74(16), 1871–1889 (2014).
  Medline CASGoogle Scholar
• 44 Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. Patient acceptability of 3D printed medicines. Int. J. Pharm. 530(1–2), 71–78 (2017).
  Medline CASGoogle Scholar
• 45 Gupta SS, Solanki N, Serajuddin AT. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion, IV: affinisol HPMC HME polymers. AAPS PharmSciTech 17(1), 148–157 (2016).
  Medline CASGoogle Scholar
• 46 Zheng M, Bauer F, Birk G, Lubda D. Polyvinyl alcohol in hot melt extrusion to improve the solubility of drugs (2017). https://www.europeanpharmaceuticalreview.com/wp-content/uploads/PVA-in-HME-to-Improve-Solubility_Poster_A3_EN_MSIG_Mar2017_low.pdf (last accessed on January 11th 2018).
  Google Scholar
• 47 De Jaeghere W, De Beer T, Van Bocxlaer J, Remon JP, Vervaet C. Hot-melt extrusion of polyvinyl alcohol for oral immediate release applications. Int. J. Pharm. 492(1–2), 1–9 (2015).
  Medline CASGoogle Scholar
• 49 Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema LJIJOP. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. 509(1–2), 255–263 (2016).
  Google Scholar
• 50 Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 67(3), 217–223 (2010).
  Medline CASGoogle Scholar
• 51 Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13(2), 123–133 (2001).
  Medline CASGoogle Scholar
• 52 Saurí J, Millán D, Suñé-Negre J et al. Quality by design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets. Int. J. Pharm. 477(1–2), 431–441 (2014).
  Medline CASGoogle Scholar
• 53 Lee PI. Kinetics of drug release from hydrogel matrices. J. Control. Rel. 2, 277–288 (1985).
  CASGoogle Scholar
• 54 Long J, Gholizadeh H, Lu J, Bunt C, Seyfoddin A. Application of fused deposition modelling (FDM) method of 3D printing in drug delivery. Curr. Pharm. Des. 23(3), 433–439 (2017).
  Medline CASGoogle Scholar
• 55 Goyanes A, Kobayashi M, Martínez-Pacheco R, Gaisford S, Basit AW. Fused-filament 3D printing of drug products: microstructure analysis and drug release characteristics of PVA-based caplets. Int. J. Pharm. 514(1), 290–295 (2016).
  Medline CASGoogle Scholar
• 56 Khaled SA, Alexander MR, Irvine DJ et al. Extrusion 3D printing of paracetamol tablets from a single formulation with tunable release profiles through control of tablet geometry. AAPS PharmSciTech 19(8), 3403–3416 (2018).
  Medline CASGoogle Scholar
• 57 Gioumouxouzis CI, Katsamenis OL, Bouropoulos N, Fatouros DG. 3D printed oral solid dosage forms containing hydrochlorothiazide for controlled drug delivery. J. Drug Deliv. Sci. Technol. 40, 164–171 (2017).
  CASGoogle Scholar
• 58 Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J. Control. Release 217, 308–314 (2015).
  Medline CASGoogle Scholar